Search research articles
Contact Us
Filters
Showing results (511-520 of 546) with videos related to
Page
of 55
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 12, 2024
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network
Robin Zagala, Stephane Dalle, Marie Beylot-Barry, et al.
JAMA Dermatology
|
May 2, 2019
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival
Anaïs Vallet, Bastien Oriano, Laurent Mortier, et al.
La Revue De Medecine Interne
|
February 9, 2023
French practical guidelines for the diagnosis and management of AA amyloidosis
S Georgin-Lavialle, L Savey, D Buob, et al.
Joint Bone Spine
|
September 21, 2023
BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysis
Romain Foré, Eric Liozon, Stéphanie Dumonteil, et al.
Rheumatology (Oxford, England)
|
April 27, 2026
Belimumab use in pediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive study
Dorian Bigey-Frau, Damia Leguevaques, Heloise Reumaux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2013
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial
Florent Cachin, Elisabeth Miot-Noirault, Brigitte Gillet, et al.
Eclinicalmedicine
|
December 24, 2024
When to stop immunotherapy for advanced melanoma: the emulated target trials
Mathilde Amiot, Laurent Mortier, Stéphane Dalle, et al.
Journal of Hepatology
|
December 2, 2021
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
Marco Sanduzzi-Zamparelli, Zoe Mariño, Sabela Lens, et al.
The British Journal of Dermatology
|
November 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting
Karine Billard, Laurent Mortier, Olivier Dereure, et al.
JAMA Dermatology
|
July 16, 2020
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma
Angélique Brunot, Jean-Jacques Grob, Geraldine Jeudy, et al.
Page
of 55
Search research articles
Search
Showing results (511-520 of 546) with videos related to
Sort By:
Page
of 55
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 12, 2024
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network
Robin Zagala, Stephane Dalle, Marie Beylot-Barry, et al.
JAMA Dermatology
|
May 2, 2019
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival
Anaïs Vallet, Bastien Oriano, Laurent Mortier, et al.
La Revue De Medecine Interne
|
February 9, 2023
French practical guidelines for the diagnosis and management of AA amyloidosis
S Georgin-Lavialle, L Savey, D Buob, et al.
Joint Bone Spine
|
September 21, 2023
BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysis
Romain Foré, Eric Liozon, Stéphanie Dumonteil, et al.
Rheumatology (Oxford, England)
|
April 27, 2026
Belimumab use in pediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive study
Dorian Bigey-Frau, Damia Leguevaques, Heloise Reumaux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2013
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial
Florent Cachin, Elisabeth Miot-Noirault, Brigitte Gillet, et al.
Eclinicalmedicine
|
December 24, 2024
When to stop immunotherapy for advanced melanoma: the emulated target trials
Mathilde Amiot, Laurent Mortier, Stéphane Dalle, et al.
Journal of Hepatology
|
December 2, 2021
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
Marco Sanduzzi-Zamparelli, Zoe Mariño, Sabela Lens, et al.
The British Journal of Dermatology
|
November 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting
Karine Billard, Laurent Mortier, Olivier Dereure, et al.
JAMA Dermatology
|
July 16, 2020
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma
Angélique Brunot, Jean-Jacques Grob, Geraldine Jeudy, et al.
Page
of 55